Trial in Progress – A052101: A randomized phase 3 trial of continuous vs. intermittent maintenance therapy with zanubrutinib as upfront treatment in older patients with mantle cell lymphoma
- Citation:
- Blood vol 144 (Supplement 1) 1661.3
- Meeting Instance:
- ASH 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Anne W. Beaven Susan Geyer Jonathon Cohen Tycel Phillips Travis Dockter Priyanka Pophali Gita Thanarajasingam Gina Mazza Alvero Alencar Eric Hsi Meng Welliver Daniel Nikcevich John P. Leonard
- Networks:
- CA043, ESSENTIA, LAPS-MN026, LAPS-NC007, LAPS-WI020, NY018
- Study
- Alliance-A052101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: